[1] Misery, L., Loser, K., & Ständer, S. Sensitive skin[J]. Journal of the European Academy of Dermatology and Venereology : JEADV, 2016,30(1): 2–8.[2] Farage M. A. The Prevalence of Sensitive Skin[J]. Frontiers in medicine, 2019, 6: 98.[3] Inamadar, A. C., & Palit, A. Sensitive skin: an overview[J]. Indian journal of dermatology, venereology and leprology, 2013, 79(1): 9–16.[4] Escalas-Taberner, J., González-Guerra, E., & Guerra-Tapia, A. La piel sensible: un síndrome complejo[J]. Actas dermo-sifiliograficas, 2011, 102(8): 563–571.[5] Wu, Y., Wangari-Olivero, J., & Zhen, Y. ARTICLE: Compromised Skin Barrier and Sensitive Skin in Diverse Populations[J]. Journal of drugs in dermatology, 2021, 20(4): 17–22.[6] Proksch, E., Brandner, J. M., & Jensen, J. M. The skin: an indispensable barrier[J]. Experimental dermatology, 2008, 17(12): 1063–1072.[7] Koh, L. F., Ong, R. Y., & Common, J. E. Skin microbiome of atopic dermatitis[J]. Allergology international : official journal of the Japanese Society of Allergology, 2022, 71(1): 31–39. [8] Chen, Y., Sun, J., Chen, H., et al. Plant-Derived Bioactive Peptides: Extraction, Isolation, Purification, Pharmacological Activities, Structure-Activity Relationship, and Applications[J]. Journal of agricultural and food chemistry, 2025, 73(32): 19867–19906.[9] Bylka, W., Znajdek-Awiżeń, P., Studzińska-Sroka, E., et al. Centella asiatica in cosmetology[J]. Postepy dermatologii ialergologii,2013, 30(1): 46–49.[10] Liu, J., Xu, X., Jian, M., et al. Glycyrrhiza glabra extract as a skinwhitening Agent: Identification of active components and CRTC1/MITFpathway-inhibition mechanism[J]. Journal of ethnopharmacology, 2025, 349: 119948. [11] Jung, H. S., Kim, M. H., Gwak, N. G., et al. Antiallergic effects of Scutellaria baicalensis on inflammation in vivo and in vitro[J]. Journal of ethnopharmacology, 2012, 141(1): 345–349.[12] Zhang, P., Zhang, D., Zhou, W., et al. Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine[J]. Briefings in bioinformatics,2023, 25(1): 518.[13] Zhao, L., Zhang, H., Li, N., et al. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula[J]. Journal of ethnopharmacology, 2023, 309: 116306.[14] Chen, Y., Huang, L., Li, W., et al. Exploring skin adverse events and mechanisms of apalutamide using data mining algorithms and network pharmacology[J]. Frontiers in pharmacology, 2025, 16: 1517874.[15] Huang, J., Li, H., Liang, J., et al. Oxymatrine for treating atopic dermatitis: Network pharmacology, bioinformatics, metabolomics, and experimental validation[J]. International immunopharmacology, 2025,163: 115243.[16] Shannon, P., Markiel, A., Ozier, O., et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks[J]. Genome research, 2003, 13(11): 2498–2504.[17] Alamri, A. M., Assiri, A. A., Yousuf, A., et al. Exploring Nigella Sativa's medicinal capacity against skin cancer pathways using network pharmacology and molecular docking[J]. Scientific reports,2025, 15(1): 34609.[18] Li, S., & Zhang, B. Traditional Chinese medicine network pharmacology: theory, methodology and application[J]. Chinese journal of natural medicines, 2013, 11(2): 110–120.[19] Hameedat, F., Hawamdeh, S., Alnabulsi, S., et al. High Performance Liquid Chromatography (HPLC) with Fluorescence Detection for Quantification of Steroids in Clinical, Pharmaceutical, and Environmental Samples: A Review[J]. Molecules,2022, 27(6): 1807.[20] van Haandel, L., & Stobaugh, J. F. Folate determination in human health: UPLC-MS/MS is the emerging methodology of choice[J]. Bioanalysis, 2013, 5(24): 3023–3031.[21] Tsikas D. GC-MS and GC-MS/MS measurement of malondialdehyde (MDA) in clinical studies: Pre-analytical and clinical considerations[J]. Journal of mass spectrometry and advances in the clinical lab, 2023, 30: 10–24.[22] Ru, J., Li, P., Wang, J., et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. Journal of cheminformatics,2014, 6: 13.[23] Zhao, H., Yang, Y., Wang, S., et al. NPASS database update 2023: quantitative natural product activity and species source database for biomedical research[J]. Nucleic acids research, 2023, 51(1): D621– D628.[24] Kim S. Getting the most out of PubChem for virtual screening[J]. Expert opinion on drug discovery, 2016, 11(9): 843–855.[25] Editorial: ChemSpider a tool for Natural Products research[J]. Natural product reports, 2015, 32(8): 1163–1164.[26] Rebhan, M., Chalifa-Caspi, V., Prilusky, J., et al. GeneCards: integrating information about genes, proteins and diseases[J]. Trends in genetics, 1997, 13(4): 163.[27] Amberger, J. S., & Hamosh, A. Searching Online Mendelian Inheritance in Man (OMIM): A Knowledgebase of Human Genes and Genetic Phenotypes[J]. Current protocols in bioinformatics, 2017, 58: 1.2.1–1.2.12.[28] Piñero, J., Ramírez-Anguita, J. M., Saüch-Pitarch, J., et al. The DisGeNET knowledge platform for disease genomics: 2019 update[J]. Nucleic acids research, 2020, 48(1): D845–D855.[29] Zhou, Y., Zhang, Y., Zhao, D., et al. TTD: Therapeutic Target Database describing target druggability information[J]. Nucleic acidsresearch, 2024, 52(1): D1465–D1477.[30] Daina, A., Michielin, O., & Zoete, V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules[J]. Nucleic acids research, 2019, 47(1): W357– W364.[31] Wang, X., Shen, Y., Wang, S., et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database[J]. Nucleic acids research, 2017, 45(1):W356–W360.[32] Yao, Z. J., Dong, J., Che, Y. J., et al. TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models[J]. Journal of computer-aided molecular design, 2016,30(5): 413–424.[33]Gfeller, D., Grosdidier, A., Wirth, M., et al. SwissTarget Prediction: a web server for target prediction of bioactive small molecules[J]. Nucleic acids research, 2014, 42: W32–W38.[34]Safran, M., Dalah, I., Alexander, J., et al. GeneCards Version 3: the human gene integrator[J]. Database : the journal of biological databases and curation, 2010:20.[35]Zhang-James, Y., & Faraone, S. V. Genetic architecture for human aggression: A study of gene-phenotype relationship in OMIM[J]. American journal of medical genetics, 2016, 171(5): 641–649.[36]Kohl, M., Wiese, S., & Warscheid, B. Cytoscape: software for visualization and analysis of biological networks[J]. Methods in molecular biology, 2011, 696: 291–303.[37]Cook, H. V., Doncheva, N. T., Szklarczyk, D., et al. Viruses. STRING: A Virus-Host Protein-Protein Interaction Database[J]. Viruses, 2018, 10(10): 519.[38]Zhou, Y., Zhou, B., Pache, L., et al. Metascape provides a biologistoriented resource for the analysis of systems-level datasets[J]. Nature communications, 2019, 10(1): 1523.[39]Wang, J., Zhong, J., Chen, G., et al. ClusterViz: A Cytoscape APP for Cluster Analysis of Biological Network[J]. IEEE/ACM transactions on computational biology and bioinformatics, 2015, 12(4): 815–822.[40]Singh P. Network and pathway enrichment analysis of Attention Deficit/Hyperactivity Disorder candidate genes[J]. Indian journal of psychiatry, 2020, 62(4): 400–406.[41]Verbavatz, V., & Barthelemy, M. Betweenness centrality in dense spatial networks[J]. Physical review. E, 2022, 105(5): 054303.[42]Li, G., Li, M., Wang, J., et al. United Neighborhood Closeness Centrality and Orthology for Predicting Essential Proteins[J]. IEEE/ ACM transactions on computational biology and bioinformatics, 2020, 17(4): 1451–1458.[43]Charest, J., Loebenstein, P., Mach, R. L., et al. FunFEA: an R package for fungal functional enrichment analysis[J]. BMC bioinformatics, 2025, 26(1): 138.[44]Pastorino, G., Cornara, L., Soares, S., et al. Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review[J]. Phytotherapy research, 2018, 32(12): 2323–2339.[45]Kanehisa, M., Furumichi, M., Tanabe, M., et al. KEGG: new perspectives on genomes, pathways, diseases and drugs[J]. Nucleic acids research, 2017, 45: D353–D361.[46]Bai, X., Yao, M., Zhu, X., et al. Baicalin suppresses interleukin- 1β-induced apoptosis, inflammatory response, oxidative stress, and extracellular matrix degradation in human nucleus pulposus cells[J].Immunopharmacology and immunotoxicology, 2023, 45(4): 433–442. [47]Zhang, L., Liu, X., Huang, M., et al. Metformin Inhibits HaCaT Cell Proliferation Under Hyperlipidemia Through Reducing Reactive Oxygen Species via FOXO3 Activation[J]. Clinical, cosmetic and investigational dermatology, 2022, 15: 1403–1413.[48]Mekori Y. A. The mastocyte: the "other" inflammatory cell in immunopathogenesis[J]. The Journal of allergy and clinical immunology, 2004, 114(1): 52–57.[49]Bandopadhyay, S., Mandal, S., Ghorai, M., et al. Therapeutic properties and pharmacological activities of asiaticoside and madecassoside: A review[J]. Journal of cellular and molecular medicine, 2023, 27: 593–608.[50]Passante, E., & Frankish, N. The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell[J]. Inflammation research : official journal of the European Histamine Research Society,2009, 58(11): 737–745.[51]Lyu, J., Diao, Q. C., Wang, S., et al. Study on screening and evaluation methods of cosmetics for people with facial sensitive skin[J]. Medicine, 2022, 101(31): e29975.[52]Wang, Y., Viennet, C., Jeudy, A., et al. Assessment of the efficacy of a new complex antisensitive skin cream[J]. Journal of cosmetic dermatology, 2018, 17(6): 1101–1107.[53]Bylka, W., Znajdek-Awiżeń, P., Studzińska-Sroka, E., et al. Centella asiatica in dermatology: an overview[J]. Phytotherapy research, 2014, 28(8): 1117–1124.[54]Zhang, R., Zhu, X., Bai, H., et al. Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment[J]. Frontiers in pharmacology, 2019, 10: 123.[55]Pei, H., He, Z., Chen, W., et al. Network pharmacology and molecular docking analysis on the mechanism of Cordyceps militaris polysaccharide regulating immunity through TLR4/TNF-α pathwayss[J]. Journal of biochemical and molecular toxicology, 2023,37(6): e23345.[56]Jiashuo, W. U., Fangqing, Z., Zhuangzhuang, L. I., et al. Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review[J]. Journal of traditional Chinese medicine , 2022, 42(3): 479–486.[57]Karim, M. R., Morshed, M. N., Iqbal, S., et al. A Network Pharmacology and Molecular-Docking-Based Approach to Identify the Probable Targets of Short-Chain Fatty-Acid-Producing Microbial Metabolites against Kidney Cancer and Inflammation[J]. Biomolecules,2023, 13(11): 1678. [58]anehisa, M., & Goto, S. KEGG: kyoto encyclopedia of genes and genomes[J]. Nucleic acids research, 2000, 28(1): 27–30.[59]Poirel, C. L., Owens, C. C., 3rd, & Murali, T. M. Network-based functional enrichment[J]. BMC bioinformatics, 2011, 12: S14.[60]Huang, Q., Wu, L. Y., Wang, Y., et al. 2013. GOMA: functional enrichment analysis tool based on GO modules[J]. Chinese journal of cancer, 2013, 32(4): 195–204.[61]Chen, J., & Ye, W. Molecular mechanisms underlying Tao- Hong-Si-Wu decoction treating hyperpigmentation based on network pharmacology, Mendelian randomization analysis, and experimental verification[J]. Pharmaceutical biology, 2024, 62(1): 296–313.[62]Ferreira, L. G., Dos Santos, R. N., Oliva, G., et al. Molecular docking and structure-based drug design strategies[J]. Molecules, 2015, 20(7): 13384–13421.[63]Baysoy, A., Bai, Z., Satija, R., et al. The technological landscape and applications of single-cell multi-omics[J]. Nature reviews.Molecular cell biology, 2023, 24(10): 695–713.[64]Cedersund, G., & Roll, J. Systems biology: model based evaluation and comparison of potential explanations for given biological data[J]. The FEBS journal, 2009, 276(4): 903–922.[65]Sulz, M. C., Burri, E., Michetti, P., et al. Treatment Algorithms for Crohn's Disease[J]. Digestion, 2020, 101: 43–57.[66]Pitarch, B., Chagoyen, M., Ranea, J. A. G., et al. A review on Gene Ontology evaluations[J]. Database : the journal of biological databases and curation, 2025:58.[67]Kanehisa M. The KEGG database[J]. Novartis Foundation symposium, 2022, 247: 91–252.[68]Gudapati, H., Torigoe, R. M. S., Tahmasebifar, A., et al. Firstin- kind 3D bioprinted human skin model using recombinant human collagen[J]. Archives of dermatological research, 2025, 317(1): 704.[69] Shin, H., Kim, S. E., Kim, C. Y., et al. M. Skin irritation testing using human iPSCs derived 3D skin equivalent model[J]. PloS one, 2025, 20(8): e0330306.